BIOLINERX Ltd/S (BLRX) Posts Quarterly Earnings Results, Meets Expectations

Share on StockTwits

BIOLINERX Ltd/S (NASDAQ:BLRX) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.06) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.06), Morningstar.com reports.

Shares of BLRX traded down $0.01 during trading hours on Friday, hitting $0.70. 391,694 shares of the stock were exchanged, compared to its average volume of 1,728,884. BIOLINERX Ltd/S has a 12-month low of $0.67 and a 12-month high of $1.84. The stock has a market capitalization of $78.77 million, a price-to-earnings ratio of -2.59 and a beta of 0.87.

A hedge fund recently bought a new stake in BIOLINERX Ltd/S stock. Fosun International Ltd purchased a new position in shares of BIOLINERX Ltd/S (NASDAQ:BLRX) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,357,415 shares of the biotechnology company’s stock, valued at approximately $1,412,000. Fosun International Ltd owned approximately 1.27% of BIOLINERX Ltd/S as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 34.69% of the company’s stock.

Several analysts recently commented on BLRX shares. HC Wainwright set a $4.00 price target on BIOLINERX Ltd/S and gave the stock a “buy” rating in a research report on Wednesday, October 3rd. ValuEngine upgraded BIOLINERX Ltd/S from a “hold” rating to a “buy” rating in a research report on Thursday, October 4th. Zacks Investment Research upgraded BIOLINERX Ltd/S from a “hold” rating to a “buy” rating and set a $1.00 price target for the company in a research report on Thursday, August 16th. Maxim Group reiterated a “buy” rating and set a $2.00 price target on shares of BIOLINERX Ltd/S in a research report on Monday, August 13th. Finally, MED started coverage on BIOLINERX Ltd/S in a research report on Wednesday, August 1st. They set a “market perform” rating for the company. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $2.50.

TRADEMARK VIOLATION NOTICE: This story was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3928844/biolinerx-ltd-s-blrx-posts-quarterly-earnings-results-meets-expectations.html.

BIOLINERX Ltd/S Company Profile

BioLineRx Ltd., a clinical stage biopharmaceutical development company focused on oncology and immunology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of multiple cancer and hematological indications; AGI-134, an immuno-oncology agent in development for solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of benign skin lesions.

Read More: Why does a company issue an IPO?

Earnings History for BIOLINERX Ltd/S (NASDAQ:BLRX)

Receive News & Ratings for BIOLINERX Ltd/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLINERX Ltd/S and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Insureum Achieves Market Cap of $0.00
Insureum Achieves Market Cap of $0.00
Reviewing Geovax Labs  & Its Competitors
Reviewing Geovax Labs & Its Competitors
LPL Financial  Price Target Lowered to $66.00 at Morgan Stanley
LPL Financial Price Target Lowered to $66.00 at Morgan Stanley
Westaim  and Becton Dickinson and  Financial Contrast
Westaim and Becton Dickinson and Financial Contrast
Reviewing Heritage Global  and J2 Global
Reviewing Heritage Global and J2 Global
United Microelectronics  Stock Price Up 6.5%
United Microelectronics Stock Price Up 6.5%


Leave a Reply

© 2006-2018 Ticker Report